{"id":70723,"date":"2026-05-12T09:57:27","date_gmt":"2026-05-12T09:57:27","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70723"},"modified":"2026-10-15T10:33:58","modified_gmt":"2026-10-15T10:33:58","slug":"kisspeptin-10","status":"publish","type":"product","link":"https:\/\/medsbase.com\/de\/product\/kisspeptin-10\/","title":{"rendered":"Kisspeptin-10"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Kurze Antwort \u2014 Was ist Kisspeptin-10?<\/h3>\n<p style=\"margin: 0;\"><strong>Kisspeptin-10<\/strong> (KP-10) is a 10-amino-acid C-terminally amidated peptide and the most-studied active fragment of the KISS1 gene product. It is the apical endogenous regulator of GnRH neuronal activity \u2014 published studies established it as the upstream switch that initiates puberty and drives pulsatile gonadotropin release. Acts via the GPR54 (KISS1R) G-protein-coupled receptor. Supplied in 5\u00a0mg and 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Was Sie bei MedsBase erhalten:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/de\/reviews\/\">Kundenbewertungen<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Jede Bestellung ist durch unsere <a href=\"https:\/\/medsbase.com\/de\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> abgedeckt \u2014 wenn Ihr Paket nicht innerhalb von 20 Werktagen ankommt, versenden wir es erneut.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Spezifikation<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS-Nummer<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">374675-21-5 (Kisspeptin-10, human)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Molekularformel<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>63<\/sub>H<sub>83<\/sub>N<sub>17<\/sub>O<sub>14<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Molekulargewicht<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">1302.45 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequenz<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH<sub>2<\/sub> (YNWNSFGLRF-NH<sub>2<\/sub>, 10 Aminos\u00e4uren; C-terminal amidierter aktiver Fragment des 54-aa reifen Kisspeptins)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Form<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilisat (wei\u00df bis leicht gelblich)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Reinheit<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC-best\u00e4tigt, COA auf Anfrage)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Lagerung<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilisat: 2\u20138 \u00b0C (K\u00fchlschrank) f\u00fcr Arbeitsvorrat; \u221220 \u00b0C zur Langzeitlagerung unge\u00f6ffneter Fl\u00e4schchen. Rekonstituiert: 2\u20138 \u00b0C, innerhalb von ~30 Tagen verwenden. Vor Licht sch\u00fctzen. Die rekonstituierte L\u00f6sung nicht einfrieren und auftauen.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>L\u00f6slichkeit<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bakteriostatisches Wasser (empfohlen) oder steriles Wasser f\u00fcr k\u00fcrzere Anwendungszeitr\u00e4ume<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Was ist Kisspeptin-10?<\/h2>\n<p><strong>Kisspeptin-10<\/strong> (KP-10) is a 10-amino-acid peptide and the most extensively studied active fragment of the KISS1 gene product, a 145-amino-acid preprokisspeptin that is processed into the 54-amino-acid mature kisspeptin and several shorter C-terminal active fragments (kisspeptin-14, kisspeptin-13, kisspeptin-10). All of the shorter fragments share the C-terminal 10-residue active core and have comparable potency at the kisspeptin receptor \u2014 kisspeptin-10 is the shortest fully active form and is by far the most common peptide in the kisspeptin literature. The well-characterised sequence is YNWNSFGLRF-NH<sub>2<\/sub>, Molekulargewicht 1302,45 Da, empirische Formel C<sub>63<\/sub>H<sub>83<\/sub>N<sub>17<\/sub>O<sub>14<\/sub>. Die C-terminale Amidierung ist essenziell f\u00fcr volle Rezeptoraktivit\u00e4t. KISS1 wurde urspr\u00fcnglich von Lee et al. (Cancer Res 1996) als Metastasierungs-Suppressor-Gen identifiziert und zu Ehren von Hershey, Pennsylvania (Heimat der Hershey\u2019s Kisses Schokoladen), wo das Gen erstmals kloniert wurde, in Kisspeptin umbenannt. Die reproduktive Rolle \u2013 KISS1\/GPR54 als apicaler Regulator der GnRH-Neuronen und molekularer Gatekeeper der Pubert\u00e4t \u2013 wurde 2003 in zwei unabh\u00e4ngigen Publikationen (Seminara et al., NEJM; de Roux et al., PNAS) etabliert, die zeigten, dass loss-of-function GPR54-Mutationen beim Menschen idiopathischen hypogonadotropen Hypogonadismus verursachen. Kisspeptin-10 wird als hochreines lyophilisiertes Pulver zur Rekonstitution mit bakterienstatischem Wasser geliefert. Es ist <strong>nicht zugelassen<\/strong> by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use, although ongoing IVF and infertility is investigating clinical applications. <\/p>\n<h2>Wirkmechanismus \u2013 GPR54 \/ KISS1R-Signalgebung und die HPG-Achse<\/h2>\n<p>What makes kisspeptin-10 mechanistically distinctive among reproductive-peptides is its position as the <strong>apikaler upstream-Regulator<\/strong> of the entire hypothalamic-pituitary-gonadal (HPG) axis. The peptide acts at a single receptor \u2014 GPR54 (also called KISS1R) \u2014 but the downstream cascade controls the full reproductive endocrine system in published studies:<\/p>\n<ul>\n<li><strong>GPR54 (KISS1R)-Aktivierung an GnRH-Neuronen<\/strong> \u2013 Kisspeptin-10 bindet an GPR54, einen Klasse-A-G-Protein-gekoppelten Rezeptor, der dicht an GnRH-Neuronenzellk\u00f6rpern im hypothalamischen arkuaten und anteroventralen periventrikul\u00e4ren Kern exprimiert wird. Die Rezeptoraktivierung koppelt an G\u03b1<sub>q\/11<\/sub> und Phospholipase C, erh\u00f6ht intrazellul\u00e4res Calcium und l\u00f6st GnRH-Neuronendepolarisation und pulsatilen GnRH-Aussto\u00df in das hypophys\u00e4re Portalsystem aus. Dies ist der direkteste Mechanismus \u2013 das Feuern der GnRH-Neuronen ist der geschwindigkeitsbestimmende Schritt der HPG-Achsenaktivit\u00e4t, und Kisspeptin ist der wichtigste endogene Stimulus.<\/li>\n<li><strong>Pulsatile vs. Surge-Modus-Regulation der HPG-Achse<\/strong> \u2014 Kisspeptin neurons in the arcuate nucleus drive the pulsatile GnRH\/LH pattern that maintains gonadal function throughout adult reproductive life. A separate population of kisspeptin neurons in the anteroventral periventricular nucleus (in rodents) generates the preovulatory LH surge in females. Studies using selective stimulation or knockout of these populations has dissected the two modes of HPG-axis output in published studies.<\/li>\n<li><strong>Pubert\u00e4tsbeginn und der \u201cKisspeptin-Schalter\u201d<\/strong> \u2014 Loss-of-function GPR54 mutations cause complete failure of puberty onset in humans and animal models; gain-of-function mutations cause central precocious puberty. The &#8220;kisspeptin switch&#8221; hypothesis \u2014 that puberty is initiated when arcuate kisspeptin neurons reach a critical activity threshold \u2014 is the dominant model of pubertal onset in current reproductive neuroscience studies.<\/li>\n<\/ul>\n<p>Kisspeptin-10 has a relatively short plasma half-life (~5\u201310 minutes) due to rapid proteolytic cleavage, particularly at the central RF amide motif by matrix metalloproteinases. Subcutaneous, intravenous, and intracerebroventricular routes are all documented in published studies; the central route is reserved for mechanism-of-action studies in rodents where the BBB-crossing question is relevant. For systemic HPG-axis studies, peripheral administration produces measurable GnRH\/LH responses within minutes of bolus injection. <\/p>\n<h2>Published Evidence<\/h2>\n<p>Kisspeptin-10 is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Reproduktive Endokrinologie und HPG-Achsen-Pharmakologie<\/strong> \u2014 pulsatile GnRH\/LH\/FSH-Dynamik, gonadale Feedback-Regulation, Sexualsteroid-Feedback auf die Aktivit\u00e4t von Kisspeptin-Neuronen (Seminara et al., NEJM 2003; de Roux et al., PNAS 2003)<\/li>\n<li><strong>Puberty studies<\/strong> \u2014 Zeitpunkt des Pubert\u00e4tsbeginns in Nagetiermodellen, Aktivierungsmuster von Kisspeptin-Neuronen w\u00e4hrend des Pubert\u00e4ts\u00fcbergangs, mechanistische Aufschl\u00fcsselung der zentralen vorzeitigen Pubert\u00e4t<\/li>\n<li><strong>Hypogonadotropic hypogonadism studies<\/strong> \u2014 preclinical models of GPR54 loss-of-function, kisspeptin-replacement protocols, mechanism-of-action studies for novel hypogonadism therapies<\/li>\n<li><strong>IVF and ovulation induction studies<\/strong> \u2014 alternatives to hCG trigger in IVF protocols, comparative LH-surge induction; clinical translation has reached Phase 2 in some studies programmes although kisspeptin-10 itself is not approved<\/li>\n<li><strong>Polycystic ovary syndrome (PCOS) studies<\/strong> \u2014 altered kisspeptin tone in PCOS preclinical models, LH-pulse frequency abnormalities, follicular maturation studies<\/li>\n<li><strong>Metastasierungsunterdr\u00fcckung und Krebsbiologie<\/strong> \u2014 KISS1 was originally identified as a metastasis-suppressor gene; published studies continues to investigate kisspeptin&#8217;s anti-metastatic activity in breast, melanoma, and pancreatic cancer models<\/li>\n<li><strong>Cardiovascular and metabolic support<\/strong> \u2014 neu entdeckte KISS1R-Expression auf Kardiomyozyten und pankreatischen \u03b2-Zellen; Effekte auf die Glukosehom\u00f6ostase und kardiale Kontraktilit\u00e4t werden untersucht<\/li>\n<li><strong>Comparative reproductive peptide studies<\/strong> \u2014 Benchmarking gegen <a href=\"https:\/\/medsbase.com\/de\/pt-141\/\">PT-141 (Bremelanotid)<\/a> for melanocortin-axis sexual-behaviour studies and against <a href=\"https:\/\/medsbase.com\/de\/oxytocin-acetate\/\">Oxytocin Acetat<\/a> f\u00fcr affilative und soziale Bindungs-Endpunkte.<\/li>\n<\/ul>\n<p>F\u00fcr einen breiteren Kontext, wo Kisspeptin-10 in das Spektrum der reproduktiven und ZNS-aktiven Peptide einzuordnen ist, siehe <a href=\"https:\/\/medsbase.com\/de\/pt-141\/\">PT-141<\/a> (melanocortin agonist for sexual behaviour studies), <a href=\"https:\/\/medsbase.com\/de\/oxytocin-acetate\/\">Oxytocin Acetat<\/a> (Neuropeptid f\u00fcr affiliatives Verhalten), und <a href=\"https:\/\/medsbase.com\/de\/sermorelin\/\">Sermorelin<\/a> (GHRH-axis hypothalamic-pituitary studies). Browse the full <a href=\"https:\/\/medsbase.com\/de\/peptides\/\">Peptid-Katalog<\/a> f\u00fcr verwandte Verbindungen. <\/p>\n<h2>Verf\u00fcgbare St\u00e4rken und Konzentrationen<\/h2>\n<p>MedsBase stocks Kisspeptin-10 in two lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Vial-St\u00e4rke<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Typischer Anwendungsfall<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Packungsgr\u00f6\u00dfen<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 pilot dosing, HPG-axis pulse protocols, single-cohort studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 oder 30 Vials<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Langzeitprotokolle, Multikohortenstudien, niedrigste Kosten pro mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 oder 30 Vials<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Both strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when users want to minimise injection volume in rodent protocols. Because kisspeptin-10 dose ranges are in the low-microgram regime per administration, a single 5\u00a0mg vial supports many weeks of pulse-protocol use at typical doses. <\/p>\n<h2>Vergleich \u2014 Kisspeptin-10 vs PT-141<\/h2>\n<p>Kisspeptin-10 und <a href=\"https:\/\/medsbase.com\/de\/pt-141\/\">PT-141 (Bremelanotid)<\/a> are both small CNS-active peptides used in reproductive- and sexual-behaviour studies, but they act on fundamentally different pathways. Kisspeptin-10 acts on the endocrine HPG axis at the GnRH-neuron level; PT-141 acts on the melanocortin behavioural-sexual axis at the MC4R level. The two are mechanistically complementary rather than competing in study models. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Kriterium<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Kisspeptin-10<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">PT-141 (Bremelanotid)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>L\u00e4nge<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 Aminos\u00e4uren (Decapeptid)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 Aminos\u00e4uren (zyklisches Heptapeptid)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Prim\u00e4rer Rezeptor<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">GPR54 \/ KISS1R<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">MC3R \/ MC4R Melanokortin-Rezeptoren<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Hauptwirkung<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">GnRH\/LH\/FSH-Freisetzung (endokrin)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">ZNS-vermitteltes Sexualverhalten (behavioral)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Studies domain<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">HPG-Achse, Pubert\u00e4t, Hypogonadismus, IVF<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sexuelles Verlangen, Erregung, erektile Funktion<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Plasmahalbwertszeit<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~5\u201310 min<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~2 Stunden (SC)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Klinisch zugelassene Anwendung<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">None (Phase 2 in IVF studies)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">FDA-approved as Vyleesi for HSDD (different molecule from pharmaceutical-grade)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typische Dosis<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u2013200 mcg, Bolus oder Puls<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">0,25\u20132 mg, einmalige Verabreichung<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The two peptides address different layers of reproductive biology \u2014 kisspeptin-10 the endocrine HPG axis, PT-141 the CNS-mediated behavioural axis \u2014 so they are not direct alternatives. Studies interested in pulsatile GnRH\/LH dynamics, puberty timing, or hypogonadism uses kisspeptin-10. Studies interested in CNS-mediated sexual-arousal pathways uses PT-141. <\/p>\n<h2>Lagerung und Rekonstitution<\/h2>\n<p><strong>Vor der Rekonstitution:<\/strong> Lagern Sie lyophilisierte Fl\u00e4schchen gek\u00fchlt bei 2\u20138 \u00b0C in der Originalverpackung f\u00fcr kurzfristige Arbeitsbest\u00e4nde. F\u00fcr unge\u00f6ffnete Langzeitlagerung einfrieren bei \u221220 \u00b0C. Lyophilisiertes Kisspeptin-10 ist unter K\u00fchlung bis zu 24 Monate und bei \u221220 \u00b0C bis zu 36 Monate stabil. Vermeiden Sie Gefrier-Tau-Zyklen des lyophilisierten Pulvers. <strong>Rekonstitutionsverfahren:<\/strong> inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5\u00a0mg vial, 2.0\u00a0mL of bacteriostatic water yields a 2.5\u00a0mg\/mL working concentration \u2014 0.04\u00a0mL delivers a 100\u00a0mcg dose. For lower-dose work, further dilution into bacteriostatic water (with optional BSA carrier protein at 0.1%) can be used. Swirl gently \u2014 do <strong>nicht<\/strong> Sch\u00fctteln Sie \u2014 und lassen Sie 2\u20135 Minuten f\u00fcr die vollst\u00e4ndige Aufl\u00f6sung. Eine korrekt rekonstituierte L\u00f6sung sollte klar und farblos sein. <strong>gek\u00fchlt bei 2\u20138 \u00b0C lagern und innerhalb von 30 Tagen verwenden. Rekonstituierte L\u00f6sung nicht einfrieren.<\/strong> Lagern Sie gek\u00fchlt bei 2\u20138 \u00b0C und verwenden Sie innerhalb von 30 Tagen f\u00fcr optimale Stabilit\u00e4t. Frieren Sie die rekonstituierte L\u00f6sung nicht ein \u2013 Gefrier-Tau-Zyklen beeintr\u00e4chtigen die Peptidintegrit\u00e4t. Verwerfen Sie jedes Fl\u00e4schchen, das Tr\u00fcbung, Ausf\u00e4llung oder Verf\u00e4rbung zeigt. Kisspeptin-10 ist anf\u00e4llig f\u00fcr proteolytische Spaltung am C-terminalen RF-Amid-Motiv; rekonstituierte L\u00f6sung sollte innerhalb des 30-Tage-Fensters f\u00fcr Protokolle mit enger Dosis-Wirkungs-Kalibrierung prompt verwendet werden. <\/p>\n<h2 id=\"faqs\">H\u00e4ufig gestellte Fragen<\/h2>\n<h3>What is Kisspeptin-10 used for in studies?<\/h3>\n<p>Kisspeptin-10 is used in studies investigating the hypothalamic-pituitary-gonadal (HPG) axis, GnRH neuron activity, pulsatile gonadotropin release, puberty onset, hypogonadotropic hypogonadism, polycystic ovary syndrome (PCOS), IVF and ovulation-induction alternatives to hCG, cancer metastasis suppression (KISS1 was originally identified as a metastasis-suppressor gene), and emerging cardiometabolic kisspeptin signalling. It is the canonical tool for KISS1R \/ GPR54 pharmacology. The pharmaceutical-grade kisspeptin-10 sold here is <strong>nicht<\/strong> FDA-approved and is supplied strictly for clinical studies use only. <\/p>\n<h3>Wie unterscheidet sich Kisspeptin-10 von PT-141?<\/h3>\n<p>Both are small CNS-active reproductive peptides, but they target different receptors and biological layers. Kisspeptin-10 acts on the GPR54\/KISS1R receptor on GnRH neurons and drives the endocrine HPG axis (LH, FSH, gonadal steroid production). PT-141 acts on MC3R\/MC4R melanocortin receptors in the CNS and drives behavioural-sexual responses (desire, arousal, erectile function). The two are mechanistically complementary and address different studies questions. <\/p>\n<h3>Was ist der Unterschied zwischen Kisspeptin-10 und Kisspeptin-54?<\/h3>\n<p>Both are active fragments of the KISS1 gene product. Kisspeptin-54 (also called metastin) is the full-length mature 54-amino-acid peptide secreted in vivo. Kisspeptin-10 is the C-terminal 10-amino-acid active core, which retains essentially full receptor potency and is the most commonly used peptide because its smaller size makes synthesis cheaper, purity easier to verify, and reconstitution simpler. Kisspeptin-13 and kisspeptin-14 are intermediate cleavage products that also share the active C-terminal core. All four have comparable potency at GPR54. <\/p>\n<h3>What is the typical Kisspeptin-10 dose?<\/h3>\n<p>Published preclinical protocols typically use 10\u2013200\u00a0mcg per administration in rodent models, given subcutaneously or intravenously for bolus-pulse studies, or as continuous infusion for chronic-stimulation studies. Human IVF has used 6.4\u201312.8\u00a0\u03bcg\/kg as a single subcutaneous trigger dose. A 5\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 2.5\u00a0mg\/mL \u2014 0.04\u00a0mL equals 100\u00a0mcg. <\/p>\n<h3>Ist Kisspeptin-10 von der FDA zugelassen?<\/h3>\n<p>No. Kisspeptin-10 is not approved by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. Phase 2 clinical studies in IVF ovulation induction is ongoing, but kisspeptin-10 has not been approved for any clinical indication. <\/p>\n<h3>Wie sollte Kisspeptin-10 gelagert werden?<\/h3>\n<p>Lyophilisierte Vials: gek\u00fchlt bei 2\u20138 \u00b0C f\u00fcr kurzfristige Arbeitsbest\u00e4nde oder \u221220 \u00b0C f\u00fcr die Langzeitlagerung unge\u00f6ffneter Vials. Rekonstituierte L\u00f6sung: gek\u00fchlt bei 2\u20138 \u00b0C, innerhalb von 30 Tagen verwenden. Rekonstituierte L\u00f6sung nicht einfrieren \u2014 Gefrier-Tau-Zyklen degradieren das Peptid. Immer vor direktem Licht sch\u00fctzen. F\u00fcr niedrigkonzentrierte Arbeitsverd\u00fcnnungen wird Tr\u00e4gerprotein BSA (0,1%) empfohlen, um Adsorptionsverluste zu minimieren. <\/p>\n<h3>Wie rekonstituiere ich Kisspeptin-10?<\/h3>\n<p>Befolgen Sie das oben beschriebene Rekonstitutionsverfahren. Geben Sie bakterienstatisches Wasser an der Seitenwand des Fl\u00e4schchens hinzu (nicht auf den lyophilisierten Kuchen), schwenken Sie vorsichtig und lassen Sie 2\u20135 Minuten zur vollst\u00e4ndigen Aufl\u00f6sung. Sch\u00fctteln Sie <strong>nicht<\/strong> das Fl\u00e4schchen nicht. Eine korrekt rekonstituierte L\u00f6sung ist klar und farblos. F\u00fcr ein 5 mg-Fl\u00e4schchen + 2,0 mL Verd\u00fcnnungsmittel betr\u00e4gt die Arbeitskonzentration 2,5 mg\/mL. <\/p>\n<h3>Welche St\u00e4rken f\u00fchrt MedsBase?<\/h3>\n<p>MedsBase carries Kisspeptin-10 in 5\u00a0mg and 10\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>Warum wurde KISS1 urspr\u00fcnglich als Kisspeptin bezeichnet?<\/h3>\n<p>Das KISS1-Gen wurde von Lee et al. in Hershey, Pennsylvania, als Metastasen-Suppressor-Gen entdeckt (Cancer Res 1996). Der Name \u201cKisspeptin\u201d war eine scherzhafte Anspielung auf Hershey\u2019s Kisses, die ikonischen Schokoladen aus derselben Stadt. Die reproduktive Rolle wurde erst 2003 mit der gleichzeitigen Ver\u00f6ffentlichung von Studien zu GPR54-Mutations-Hypogonadismus beim Menschen im NEJM (Seminara et al.) und PNAS (de Roux et al.) charakterisiert. Das Peptid hat somit die ungew\u00f6hnliche Auszeichnung, sowohl als Krebsmetastasen-Suppressor als auch als apicaler Regulator der Pubert\u00e4t charakterisiert zu werden \u2013 zwei Rollen, die mechanistisch noch nicht vollst\u00e4ndig verbunden sind. <\/p>\n<h3>Does Kisspeptin-10 cause side reported effects?<\/h3>\n<p>Published preclinical and Phase 1\/2 clinical studies has documented good tolerability at typical doses. The predominant on-target effects are HPG-axis activation \u2014 rising LH, FSH, testosterone (males) or estradiol (females), and downstream gonadal steroid effects. Off-target findings include modest cardiovascular effects mediated by KISS1R expression on vascular tissue, and a flushing\/vasodilation effect noted in some human studies at higher doses. Long-term safety data outside contexts is limited. <\/p>\n<h3>Wie ist die Halbwertszeit von Kisspeptin-10?<\/h3>\n<p>In preclinical and clinical studies, kisspeptin-10 has a plasma half-life of approximately 5\u201310 minutes following intravenous or subcutaneous administration. The short half-life is due to rapid proteolytic cleavage by matrix metalloproteinases at the central RF-amide motif. For chronic-stimulation studies, continuous infusion or repeated pulse-dosing protocols are used to maintain receptor occupancy. <\/p>\n<h3>How long does Kisspeptin-10 take to show effects in preclinical studies?<\/h3>\n<p>Acute LH responses to bolus kisspeptin-10 administration are detectable within 5\u201315 minutes in rodent and human studies. FSH and downstream gonadal steroid responses develop over hours to days. Chronic-stimulation effects on puberty timing in young rodent models manifest over the natural pubertal window \u2014 days to weeks depending on species and developmental stage at intervention. <\/p>\n<h3>Kann ich Kisspeptin-10 f\u00fcr den internationalen Versand bestellen?<\/h3>\n<p>Ja. MedsBase versendet Kisspeptin-10 weltweit \u00fcber unser spezielles Peptid-Versandnetzwerk. Bestellungen, die nur Peptide enthalten, qualifizieren sich f\u00fcr unseren eigenst\u00e4ndigen Peptid-Versandservice. Alle Bestellungen werden in temperaturkontrollierter Verpackung mit vollst\u00e4ndiger Sendungsverfolgung versandt und sind abgedeckt durch unser <a href=\"https:\/\/medsbase.com\/de\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance Policy<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Reproductive, CNS, and Behavioural Studies<\/h2>\n<ul>\n<li><a href=\"\/de\/pt-141\/\"><strong>PT-141 (Bremelanotid)<\/strong><\/a> \u2014 Cyclic heptapeptide melanocortin agonist \u2014 CNS-mediated sexual-behaviour studies<\/li>\n<li><a href=\"\/de\/oxytocin-acetate\/\"><strong>Oxytocin Acetat<\/strong><\/a> \u2014 9-aa cyclic neuropeptide \u2014 social-bonding and affiliative behavioural support<\/li>\n<li><a href=\"\/de\/sermorelin\/\"><strong>Sermorelin<\/strong><\/a> \u2014 GHRH(1-29) analog \u2014 hypothalamic-pituitary-axis studies<\/li>\n<li><a href=\"\/de\/cjc-1295-with-dac\/\"><strong>CJC-1295 mit DAC<\/strong><\/a> \u2014 Long-acting GHRH analog \u2014 growth-axis studies<\/li>\n<li><a href=\"\/de\/selank\/\"><strong>Selank<\/strong><\/a> \u2014 Anxiolytic heptapeptide \u2014 GABA \/ BDNF stress resilience<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Weiterf\u00fchrende Literatur<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore reproductive and CNS-active peptides<\/strong><\/p>\n<p style=\"margin: 0;\">Durchst\u00f6bern Sie das gesamte Sortiment <a href=\"https:\/\/medsbase.com\/de\/peptides\/\"><strong>Peptid-Katalog<\/strong><\/a>, mit verwandten Verbindungen einschlie\u00dflich <a href=\"https:\/\/medsbase.com\/de\/pt-141\/\">PT-141 (Bremelanotid)<\/a> for melanocortin sexual-behaviour studies, <a href=\"https:\/\/medsbase.com\/de\/oxytocin-acetate\/\">Oxytocin Acetat<\/a> for affiliative-behaviour studies, and <a href=\"https:\/\/medsbase.com\/de\/sermorelin\/\">Sermorelin<\/a> for hypothalamic-pituitary-axis studies.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Apikaler Regulator der GnRH-Neuronenaktivit\u00e4t<br \/>\n\u2705 KISS1R \/ GPR54-Rezeptoragonist<br \/>\n\u2705 HPG-axis &amp; puberty compound<br \/>\n\u2705 IVF and ovulation-induction studies<br \/>\n\u2705 Urspr\u00fcnglich als Metastasierungsunterdr\u00fccker identifiziert<\/p>\n<p><strong>Kisspeptin-10<\/strong> enth\u00e4lt synthetische Peptidverbindung.<\/p>","protected":false},"featured_media":70963,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6277,5441],"class_list":["post-70723","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-kisspeptin","product_tag-peptide","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product\/70723","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/comments?post=70723"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/media\/70963"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/media?parent=70723"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product_brand?post=70723"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product_cat?post=70723"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product_tag?post=70723"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}